Cisplatin: all 1,652 studies that test it

Page 17 of 17. Open to participants first (223), then studies with results posted, then the rest; newest registration first within each.

• Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder CancerCompletedNCT00003133Phase 1
• Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable CancerCompletedNCT00003132Phase 1
• Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the EsophagusCompletedNCT00003118Phase 3
• Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung CancerCompletedNCT00003111Phase 2
• Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced CancerCompletedNCT00003108Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder CancerCompletedNCT00003105Phase 1/2
• Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the EsophagusCompletedNCT00003087Phase 2
• Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the CervixCompletedNCT00003078Phase 3
• Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric CancerCompletedNCT00003055Phase 2
• Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT00003037Phase 1/2
• Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the PancreasCompletedNCT00003029Phase 3
• Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic MelanomaCompletedNCT00003027Phase 3
• Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast CancerCompletedNCT00002998Phase 2
• Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the UterusTerminatedNCT00002993Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the EsophagusCompletedNCT00002984Phase 1/2
• Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and NeckCompletedNCT00002932Phase 2
• Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian CancerCompletedNCT00002913Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00002888Phase 3
• Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the EsophagusCompletedNCT00002883Phase 3
• Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With MelanomaCompletedNCT00002882Phase 3
• Etoposide Plus Cisplatin in Treating Patients With Recurrent EpendymomasCompletedNCT00002876Phase 2
• High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerCompletedNCT00002854Phase 1
• Combination Chemotherapy in Treating Patients With LymphomaCompletedNCT00002835Phase 3
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical CancerCompletedNCT00002813Phase 2
• Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach CancerCompletedNCT00002783Phase 2
• SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or TongueTerminatedNCT00002735Phase 2
• High-Dose Chemotherapy in Treating Patients With Advanced Stomach CancerCompletedNCT00002722Phase 2
• Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00002717Phase 3
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the EsophagusCompletedNCT00002711Phase 1
• Combination Chemotherapy in Patients With Advanced Urinary Tract CancerCompletedNCT00002684Phase 2
• Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck CancerCompletedNCT00002654Phase 3
• SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT00002642Phase 2
• Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsCompletedNCT00002608Phase 2
• Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically RemovedCompletedNCT00002583Phase 3
• Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial CancerCompletedNCT00002568Phase 3
• Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's LymphomaCompletedNCT00002565Phase 3
• Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous CisplatinCompletedNCT00002559Phase 1/2
• High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck CancerCompletedNCT00002555Phase 3
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the UterusCompletedNCT00002546Phase 3
• Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical CancerCompletedNCT00002536Phase 3
• Combination Chemotherapy in Treating Patients With AIDS-Related LymphomaCompletedNCT00002524Phase 2
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00002522Phase 2
• Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00002521Phase 2
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial CancerCompletedNCT00002493Phase 3
• Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination ChemotherapyStatus unknownNCT00002488Phase 2
• Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaStatus unknownNCT00002481Phase 2
• Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS TumorsCompletedNCT00002472Phase 2
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaCompletedNCT00002461Phase 2
• Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal CarcinomatosisCompletedNCT00001569Phase 1
• Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00001499Phase 2
• Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLCCompletedNCT00001450Phase 2
• A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian CancerCompletedNCT00001426Phase 2

← Cisplatin overview